Macrolide-Resistant Bordetella pertussis, Vietnam, 2016-2017.

Kazunari Kamachi, Hong T Duong, Anh D Dang, T Hai, Do Do, Kentaro Koide, Nao Otsuka, Keigo Shibayama, Ha Thi Thu Hoang
Author Information

Abstract

Macrolide-resistant Bordetella pertussis emerged in Vietnam during 2016-2017. Direct analyses of swab samples from 10 patients with pertussis revealed a macrolide-resistant mutation, A2047G, in the 23S rRNA. We identified the MT104 genotype of macrolide-resistant B. pertussis (which is prevalent in mainland China) and its variants in these patients.

Keywords

References

  1. Clin Microbiol Infect. 2014 Nov;20(11):O825-30 [PMID: 24816168]
  2. Emerg Infect Dis. 2019 Dec;25(12):2205-2214 [PMID: 31742507]
  3. Antimicrob Agents Chemother. 2013 Oct;57(10):5193-4 [PMID: 23877687]
  4. PLoS One. 2015 Sep 25;10(9):e0138941 [PMID: 26406905]
  5. Jundishapur J Microbiol. 2014 Jun;7(6):e10880 [PMID: 25371806]
  6. Jundishapur J Microbiol. 2015 Jul 25;8(7):e18190 [PMID: 26396713]
  7. Pediatr Infect Dis J. 2019 Apr;38(4):370-376 [PMID: 30882726]
  8. Emerg Microbes Infect. 2019;8(1):461-470 [PMID: 30898080]
  9. Int J Infect Dis. 2017 Sep;62:56-58 [PMID: 28751008]

MeSH Term

Anti-Bacterial Agents
Bordetella pertussis
China
Drug Resistance, Bacterial
Erythromycin
Humans
Macrolides
RNA, Ribosomal, 23S
Vietnam

Chemicals

Anti-Bacterial Agents
Macrolides
RNA, Ribosomal, 23S
Erythromycin